Copy of Newspaper Publication

August 01, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Compliance pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, With reference to the above subject, please find attached herewith copy of Newspaper Advertisement dated August 01, 2026 in Financial Express (English edition) and in Financial Express (Gujarati edition) for publication of copy of extract of Financial Results for the Quarter Ended June 30, 2026. Kindly take the same on record. Thanking You. Yours Faithfully, For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 Encl: As above ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in Haldia Petrochemicals Limited CIN:U24100WB2015PLC205383 RegisteredOffice:BengalEcoIntelligentPark,Tower1,BlockEM,PlotNo.3 (cid:149)¬t¼¼ Š¼¼¬¼Ì, ‡¼¡¼(cid:149)ZS¼Š¼Æ(cid:149)¼, @¼û¼y¼¡¼¼y, S¼Æ](cid:149)¼t¼-380009 SaltLakeCity,SectorV,Kolkata700091,WestBengal,India Kù¼^ ‡¼¼Ìh¬¼ Tel:03371122334,71122445|Email:corp@hpl.co.in (½¬¼Lü¼¼Ì(cid:149)Âh A‡h(cid:149)̬h (@¼Ì‡ö¼Ì¬¼™û¼Ì‡h) ½‡¼ü¼û¼¼Ì, 2002 ‡¼¼ ½‡¼ü¼û¼ 8(1) °Ìkº¼) Statement of Unaudited Standalone Financial Results for the Quarter ended on 30th June, 2026 Š¼\ ½‡¼ü¼û¼¼Ì t¼(cid:149)ÂKÌ y£¼¼™¡¼Ìÿ¼ \Ì) ‡¼¼ ½‡¼ü¼û¼ 9 ¬¼¼x¼Ì ¡¼Z[¼¼t¼Â Kÿ¼û¼ 13 (12) °Ìkº¼ û¼º¼t¼Â ¬¼u¼¼‡¼¼ÌEŠ¼ü¼¼ÌS¼ K(cid:149)‡¼Ì Unaudited Unaudited Unaudited Audited 1 TotalIncomefromOperations 45,090 42,956 15,977 127,155 yÌ¡¼¼y¼(cid:149)¼Ì‡¼ÆZ †ü¼¼‡¼ y¼Ì(cid:149)¡¼¼û¼¼Z @¼¼¡¼Ì \Ì. 2 NetProfit/(Loss)fortheperiod(beforeTax, (725) 5,872 (3,137) 2,663 Exceptionaland/orExtraordinaryitems#) ‡¼Z. ÿ¼¼Ì‡¼ @¼ÌS¼Âœû¼Ì‡h ‡¼Zù¼(cid:149) ù¼¼K (cid:149)Kû¼ 3 NetProfit/(Loss)fortheperiodbeforetax (725) 5,872 (3,137) 2,294 (afterExceptionaland/orExtraordinaryitems#) 1 yÌ¡¼¼y¼(cid:149) : û¼¼ZS¼r¼¼ —¼. 16,97,262.41/- 4 NetProfit/(Loss)fortheperiodaftertax(after (539) 4,794 (2,044) 2,448 ½¬¼½~KQ¼¼‡¼‡¼¼ Š¼Æw¼ 05.12.2022 °^(cid:149) ù¼¬¬¼¼Ì ù¼¼¬¼k @¼‡¼Ì Exceptionaland/orExtraordinaryitems#) ¬¼°-yÌ¡¼¼y¼(cid:149)((cid:149)¼Ì) : Kù¼^‡¼Â @¼ÌKt¼¼ÿ¼Â¬¼ Š¼Ð¬¼¼ Š¼Æ(cid:149)¼) 5 Total Comprehensive Income for the period (534) 4,774 (2,046) 2,421 ¦¼Â/¦¼Âû¼t¼Â £¼¼ü¼(cid:149)¼ù¼Ì‡¼ Š¼k¼r¼ S/D/W t¼¼(cid:149)ÂQ¼ 29.11.2022 û¼Æ]ù¼ [ComprisingProfit/(Loss)fortheperiod(after ü G¼ A¼½¬ Z¼ 0ö 5ú 03¼¼ 0A M‡¼ t¼ ¼Š ¼¼ (cid:149)v ¼ Q ¼@ :¼ ÌS 3¼ 0Âœû .¼ 1̇ 1h 2‡ 0¼Zù 1¼ 9(cid:149) : 27.07.2026- tax)andOtherComprehensiveIncome(after 9 PaidupDebtCapital/OutstandingDebt 58,797 49,653 47,796 49,653 2 yÌ¡¼¼y¼(cid:149) : ¦¼Â/¦¼Âû¼t¼Â °¼½¬¼ù¼ ¬¼Z[¼¼¡¼¼º¼¼ ¬¼Â/@¼¼Ì û¼¼ZS¼r¼¼ —¼. 30,35,433.53/- 10 OutstandingRedeemablePreferenceShares - - - - ¬¼°-yÌ¡¼¼y¼(cid:149)((cid:149)¼Ì) ¦¼Â/¦¼Âû¼t¼Â ‡¼½¬¼û¼¼ù¼¼‡¼ÆZ 28.02.2023 °^(cid:149) [¼¼(cid:149)¬¼¼Ì t¼Íw¼Â¬¼ @¼‡¼Ì D Eae rb nt inE gq sui Pty erR Sat hio are(ofRs10/-each)(for continuing and discontinued operations) - 1. Basic: (0.32) 2.84 (1.21) 1.45 t¼¼(cid:149)ÂQ¼ : 31.01.2019 2. Diluted: (0.32) 2.84 (1.21) 1.45 13 Capital Redemption Reserve 2,711 2,711 2,711 2,711 14 Debenture Redemption Reserve - - - - 00286/1/11+11/2, ¬¼Ì. ‡¼Z. 106/1, hÂ.Š¼Â. ¬KÂû¼ ‡¼Z. 13 Š¼ÐK ö¼A‡¼ÿ¼ Šÿ¼¼Ìh ‡¼Z. 74 Š¼ÐKÂ, û¼¼Ì]Ì-S¼¼û¼- 1 The aforesaid Standalone Financial Results have been reviewed by the Audit Committee and approved by the Board 3 yÌ¡¼¼y¼(cid:149): ¦¼Â S¼]̇„½¬¼Z° @¼Ì¬¼. [¼ZŠ¼¼¡¼t¼ û¼¼ZS¼r¼¼ —¼. 3,77,738.74/- of Directors of the Company at its meeting held on 31st July, 2026. ¬¼Â/@¼¼Ì ¬¼¼û¼Zt¼½¬¼Z° ‡¼¼Ìh¬¼‡¼Â t¼¼(cid:149)ÂQ¼ (—½Š¼ü¼¼ w¼r¼ ÿ¼¼Q¼ ¬¼Âtü¼¼Ìt¼Ì(cid:149) °^(cid:149) ¬¼¼t¼¬¼¼Ì 2 These Standalone Financial Results for the Quarter ended on 30th June 2026, have been prepared in accordance [¼ZŠ¼¼¡¼t¼ ¬¼Â/@¼¼Ì (cid:149)¼]Æú¼¼A, Kù¼^‡¼Â ÿ¼¼Ì‡¼ ‡¼Z. GAZ05001M withIndianAccountingStandards(IndASs)notifiedundertheCompanies(IndianAccountingStandards)Rules,2015 ¬¼Â/@¼¼Ì ú¼¼(cid:149)t¼ú¼¼A t¼¼(cid:149)ÂQ¼ —¼. 3,11,312.58/- and relevant provisions of the Companies Act. 2013. @¼ÌS¼Âœû¼Ì‡h ‡¼Zù¼(cid:149) : GAZ05001M 27.07.2026 (—½Š¼ü¼¼ w¼r¼ ÿ¼¼Q¼ @¼½S¼ü¼¼(cid:149) °^(cid:149) w¼r¼¬¼¼Ì t¼¼(cid:149)ÂQ¼ : 31.01.2019 ù¼¼(cid:149) @¼‡¼Ì @¼l¼¡¼‡¼ Š¼Ð¬¼¼ Š¼Æ(cid:149)¼) 3 TheaboveisanextractofthedetailedformatofQuarterlyFinancialResultsfiledwiththeStockExchangesunder & GAZ05018M t¼¼(cid:149)ÂQ¼ : 14.05.2019 ÿ¼¼Ì‡¼ ‡¼Z. GAZ05018M Regulation52oftheSEBI(ListingObligations&DisclosureRequirements)Regulations,2015.Thefullformatofthe S¼Â(cid:149)¼Ì ½û¼ÿ¼Kt¼‡¼Â ½¡¼S¼t¼ :÷ÿ¼Ìh ‡¼Z. @¼Ì/309, w¼Â^Ì û¼¼º¼ (Šÿ¼¼‡¼ û¼Æ]ù¼ ù¼Â^Ì û¼¼º¼), "‡¼¡¼_¡¼‡¼ ½¡¼°¼(cid:149)' t¼(cid:149)ÂKÌ QuarterlyFinancialResultsis availableonthewebsiteoftheStockExchange(www.bseindia.com)andalsoonthe ^r¼Ât¼Â ¬KÂû¼, ]Ƈ¼¼Ì (cid:149)Ì¡¼‡ü¼Æ ¬¼¡¼Î ‡¼Z. 254, hŠ¼Â ¬KÂû¼ ‡¼Z. 413, @¼ÌöŠ¼Â ‡¼Z. 254, û¼¼Ì]Ì-S¼Ì(cid:149)t¼Š¼Æ(cid:149), t¼¼ÿ¼ÆK¼Ì-y¬O¼ÌA, Company’s website (www.haldiapetrochemicals.com). Date : 31st July, 2026 ForHaldiaPetrochemicalsLimited @¼‡¼Ì @¼½†¼K¼(cid:149)¼Ì. Place : Kolkata Sd/- t¼¼(cid:149)ÂQ¼ : 01.08.2026 ¬¼°Â/- (@¼½†¼KÊt¼ @¼½†¼K¼(cid:149)Â) Navanit Narayan Whole-timeDirector&ChiefExecutiveOfficer ANLON HEALTHCARE LIMITED DIN:08280314 CIN:U24230GJ2013PLC077543(cid:149)RegisteredOfce:101/102,SilverCoinComplex,Opp.CrystalMall,KalawadRoad, Rajkot-360005.Gujarat(India)(cid:149)PhoneNo.+917069690081/82(cid:149)Email:info@anlonhealthcare.com(cid:149)www.anlon.in EXTRACTSOFSTANDALONEANDCONSOLIDATEDUNAUDITEDFINANCIALRESULTSFORTHEQUARTERJUNE30,2026 (Rs.InLakhsExceptPerShareData) Standalone Consolidated 3Months 3Months 3Months Year 3Months 3Months 3Months Year Particulars ended ended ended ended ended ended ended ended 30/06/2026 31/03/2026 30/06/202531/03/202630/06/2026 31/03/2026 30/06/202531/03/2026 Bharti Life Insurance Company Limited Unaudited Audited Unaudited Audited Unaudited Audited Unaudited Audited (Formerly known as Bharti AXA Life Insurance Company Limited) IRDAI Registration No: 130 dated 14 July, 2006 | CIN : U66010MH2005PLC157108 | Website: www.bhartiaxa.com TotalIncomefromOperation Registered Office: Unit No. 1902, 19th Floor, Parinee Crescenzo, 'G' Block, Bandra Kurla Complex, BKC Road, Behind MCA Ground, Bandra East, Mumbai, 1 (net) 3097.56 5542.22 3329.72 17649.87 8756.27 5088.91 3329.72 17196.56 Maharashtra-400051 NetProt/(Loss)fortheperiod(beforeTax, [SeeRegulation47(1)(b)oftheSEBI(LODR)Regulations,2015readwithIRDAI CircularReference IRDAI/F&I/REG/CIR/208/10/2016dated25th October2016. 2 Exceptionaland/orextraordinaryitems) 590.37 1261.15 500.41 4067.57 1365.99 1444.30 500.41 4250.72 NetProt/(Loss)fortheperiodbeforetax (Rs. In Lakhs) 3 (afterExceptionaland/orextraordinaryitems) 590.37 1261.15 500.41 4067.57 1365.99 1444.30 500.41 4250.72 NetProt/(Loss)fortheperiodaftertax 4 (afterExceptionaland/orextraordinaryitems) 479.71 979.20 354.69 2780.82 828.14 1107.19 354.69 2908.81 For the Period ended For the Period ended For the Year ended June 30, 2026 June 30, 2025 March 31, 2026 TotalComprehensiveIncomefortheperiod 5 (ComprisingProtfortheperiod(aftertax) 477.98 973.77 354.69 2775.73 826.25 1101.77 354.69 2903.72 andotherComprehensiveIncome(aftertax) 10630.30 5315.15 3985.15 5315.15 10630.30 5315.15 3985.15 5315.15 54,949 52,947 3,25,648 6 Paid-upEquityShareCapital (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof Rs.02/-each) Rs.10/-each) Rs.10/-each) Rs.10/-each) Rs.02/-each) Rs.10/-each) Rs.10/-each) Rs.10/-each) Reserves(ExcludingRevaluationReserve)asshown 7 intheAuditedBalanceSheetofthepreviousyear - - - 15662.12 - - - 17707.71 EarningsPerShare(FaceValue (6,882) (4,554) (7,432) 8 Rs.10perShare)BasicDi [Showing first 8,000 characters — download PDF for full document]